Business Value: Silence Therapeutics Corp (SLN)

Brandmark of Silence Therapeutics (SLN)

Silence Therapeutics management is currently optimizing internal regulations for large-scale trials, leveraging the authority of its scientists. The technology stack is based on AI modeling and partial automation of drug synthesis. This price action snapshot on GURU.Markets shows an Enterprise Value of 1153.04, confirming the company's drive for global leadership in the RNA interference segment through strategic alliances with corporate behemoths.

Silence Therapeutics Corp (SLN) - Total Company Value from 11/23/2025 to 10/29/2026

Summary analytical data breakdowns for Silence Therapeutics (SLN)

- stock price and consensus target price:
Price Chart Silence Therapeutics PLC|SLN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Silence Therapeutics|SLN - Enterprise Value
- balance sheet net asset value indicators:
Equity per Share Silence Therapeutics|SLN - Company Book Value|Capitalization to Book Value Ratio silence-therapeutics.com|SLN - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Silence Therapeutics|SLN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient silence-therapeutics.com|SLN - Company Aggregate Debts|Debts to Net Assets Silence Therapeutics|SLN - Company Long-Term Debt|Company Short-Term Debt Silence Therapeutics|Immediate Liquidity silence-therapeutics.com
- earnings and valuation multiples indicators:
SLN - Company Net Income
Summary company analytics:SLN Silence Therapeutics PLC
Original product of Silence Therapeutics plc

The development of RNA drugs and long-term royalties from pharma behemoths directly determine the dynamics of the total fundamental value of Silence Therapeutics (SLN). This indicator aggregates market capitalization and liabilities while subtracting cash, allowing an investor to assess the actual amount of capital required for a full buyout of the business, accounting for its net debt and the quality of existing assets.

Competitors of Silence Therapeutics (SLN)

Tempus AI - Total Company Value|QGEN - Total Company Value|IONS (Isis Pharmaceuticals) - Business Value|RGEN: Enterprise Value|Business Value RNA|Total Company Value CRISPR Therapeutics|Business Value WGS (GeneDx Holdings)|Enterprise Value RARE|Enterprise Value Beam Tx (BEAM)|Total Company Value Sarepta Therapeutics, Inc. SRPT|Company Buyout Price twistbioscience.com (TWST)|10x Genomics - Enterprise Value|Company Buyout Price Intellia Therapeutics Inc NTLA|Stoke (STOK) - Total Company Value|BLFS (BioLife) - Total Company Value|WVE (Wave Life Sciences) - Enterprise Value|Total Enterprise Value mazetx.com MAZE|Total Company Value Sionna Therapeutics (SION)|Prime Medicine Inc - Business Value|Enterprise Value TSHA (Taysha)|QURE - Real Price to Acquire Entire Company|MeiraGTx Holdings plc - Enterprise Value|Total Enterprise Value regenxbio.com|SLDB (Solid Biosciences) - Real Price to Acquire Entire Company|Ocugen Inc - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company PACB|BNTC (Benitec Corp) - Aggregate Business Value|Enterprise Value DSGN|RCKT (rocketpharma.com) - Value Adjusted for Debt and Cash|Enterprise Value FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics Inc. (LXEO) - Total Enterprise Value|KRRO - Total Company Value|Value Adjusted for Debt and Cash EDIT (Editas Corp)|PRQR: Enterprise Value|Codexis (CDXS) - Enterprise Value|Total Company Value Sangamo Therapeutics, Inc.|Nautilus Biotechnology Inc - Full Business Value|Enterprise Value MGX|DTIL - Total Enterprise Value|Generation Bio - Real Price to Acquire Entire Company|Enterprise Value boundlessbio.com BOLD|XCUR: Real Price to Acquire Entire Company|Imunon, Inc. - Aggregate Business Value|PHIO: Enterprise Value|MBIO - Company Buyout Price|RNAZ (TransCode Therapeutics Inc.) - Enterprise Value|Real Price to Acquire Entire Company Bionano (BNGO)|Total Company Value Applied DNA Sciences, Inc. (APDN)|Company Buyout Price bluebird bio Inc.|Total Company Value ImmunoPrecise Antibodies Ltd. IPA|Company Buyout Price Omega Therapeutics Corp (OMGA)|OMIC - Total Company Value|RGLS: Total Company Value|Syros Pharmaceuticals, Inc. (SYRS) - Total Company Value|Business Value TBIO|TCON (TRACON) - Enterprise Value|Business Value UBX (Unity Biotechnology, Inc)